DIN 02368625 — JAMP-SOTALOL 160 MG
JAMP-SOTALOL is a tablet of Sotalol marketed by JAMP PHARMA CORPORATION. The full Sotalol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02368625
- Brand name
- JAMP-SOTALOL
- Active ingredient
- Sotalol
- Strength
- 160 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- JAMP PHARMA CORPORATION
- Health Canada status
- DORMANT
- Drug class
- Class III antiarrhythmic with non-selective beta-blocking activity
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Sotalol products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02565412 | AMB-SOTALOL | 160 MG | TABLET | AMBICARE PHARMACEUTICALS INC. | MARKETED |
| 02565404 | AMB-SOTALOL | 80 MG | TABLET | AMBICARE PHARMACEUTICALS INC. | MARKETED |
| 02167794 | APO-SOTALOL | 160 MG | TABLET | APOTEX INC | MARKETED |
| 02210428 | APO-SOTALOL | 80 MG | TABLET | APOTEX INC | MARKETED |
| 02368617 | JAMP-SOTALOL | 80 MG | TABLET | JAMP PHARMA CORPORATION | DORMANT |
| 02238327 | PMS-SOTALOL - 160 MG | 160 MG | TABLET | PHARMASCIENCE INC | DORMANT |
| 02238326 | PMS-SOTALOL - 80 MG | 80 MG | TABLET | PHARMASCIENCE INC | MARKETED |